Skip to content
CityAM
Main navigation
Sign Up
  • News
    • Latest News
    • Property
    • Media
    • Technology
    • Retail and leisure
    • Transport and infrastructure
    • Law & professional services
    • Legal Notices
    • Banking
    • Politics
    • CFA Institute Talk
  • Markets & Economics
    • Markets & Economics News
    • Economics
    • Markets
    • The Trend Micro Cybersecurity Knowledge Hub
    • Talk Crypto
    • Schroders Talk
    • M&A Talk
  • Crypto A.M.
    • Crypto News
    • Crypto Magazine
    • Crypto AM Summit & Awards 2022
  • Opinion
    • Features
    • Letters
    • The City View
  • Money
    • Jobs and Money News
    • Personal Development
    • Jobs
    • Fintech
    • Money
    • Personal Finance
    • Doceo
    • Warwick Business School
  • Unwind
    • Life & Style
    • Sport
    • The Punter
    • LIV Golf
    • Travel
    • Sport Business
    • The Punter Podcast
    • Aramco Team Series
    • Culture
    • The Magazine
    • The DiverCity Podcast
  • Impact A.M.
  • Latest Paper
  • Jobs
  • CityAM Awards 2023

Shire

  • Pharma wars: Shire share price leaps as AbbVie hikes offer to £51.15

    July 8, 2014

    US-based pharmaceuticals company AbbVie has hiked its offer for Shire to £51.15 per share in the form of cash and shares. Following AbbVie's 25 June announcement it has said that it has "met with, or spoken to, a large number of Shire shareholders, who collectively represent a majority of Shire's outstanding shares". "The majority of [...]

  • AbbVie’s boss Rick Gonzalez jets in to chat up Shire investors about £27bn deal

    June 30, 2014

    The chief executive of an American drug firm chasing UK rival Shire will lay the ground for a fourth bid to buy the group this week by touring City shareholders. AbbVie chief executive and chairman Rick Gonzalez will troop around Shire’s shareholders, which include fund managers like BlackRock and Legal & General Investment Management, to [...]

  • Patent victory fortifies Shire against AbbVie

    June 25, 2014

    Pharmaceutical group Shire rejected a bid by US firm AbbVie yesterday, as it cheered a court ruling in its favour over a drug patent. Shire has already rejected the $46bn (£27.1bn) offer and said that the attempt undervalued it, reaffirming its stance today. The bid for Shire was AbbVie’s third, and it now might launch a [...]

  • Shire share price leaps by more than 500p on AbbVie approach

    June 20, 2014

    London-listed pharma company Shire has turned its nose up at an approach from AbbVie. A statement from AbbVie released this morning confirms that bids were knocked back three times. AbbVie, a Chicago based company, first offered an initial cash and share proposal in early May, valuing Shire at around £39.50 per share. By their third [...]

Posts navigation

  • Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4

Trending Articles

  • UK receives lowest ever score on corruption index as Britain's reputation suffers after a string of political scandals

  • When will the Bank of England, Federal Reserve and ECB start cutting interest rates? Sooner than you think

  • Tech Nation to shut down after government controversially gives funding to Barclays

  • British Steel and Tata Steel must go green if given £600m bailout, climate groups say

Subscribe

Subscribe to the City A.M. newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • About us
  • Advertising
  • Contact
  • Terms & Conditions
  • Privacy Policy
  • News
  • Markets & Economics
  • Opinion
  • Jobs and Money
  • Unwind
  • Crypto A.M.
  • The Punter
  • COP 26
  • Awards 2023

Follow us for breaking news and latest updates

  • Newsletters
  • Latest paper
  • Advertising
  • CryptoAM.io
  • Awards
  • About
  • Tickets
Copyright 2023 City A.M. Limited